Nitto Avecia
Steve Trahan started their work experience at Sanofi Pasteur in 2002 as a Manufacturing Associate/Senior Associate, where they were responsible for training, maintaining schedules, and overseeing batch records. Steve then became a Manufacturing Supervisor, overseeing various manufacturing processes and being the sole supervisor on weekends and holidays. After that, they became a Manufacturing Manager, managing the upstream viral manufacturing department and leading teams for Engineering, Aseptic Process Simulation Qualification, and Validation campaigns. Steve continued their career as a Manufacturing Deputy Director at Sanofi Pasteur and Emergent BioSolutions, where they were responsible for the Viral Manufacturing department and led teams for Engineering, Aseptic Process Simulation Qualification, and GMP production runs. Their most recent role is as the Director of Manufacturing Operations at Nitto Avecia, starting in 2022.
Steve Trahan received their Bachelor's degree in Biology, General from the University of Massachusetts Amherst, where they attended from 1998 to 2002.
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.